Syphilis Testing Market: By Type (Primary & Secondary Syphilis, Others), By Location of Testing (Laboratory testing, Point of care (POC) testing), and Geography

Syphilis Testing Market is estimated to be valued at USD 1,538.4 Million in 2023 and is poised to grow at a significant CAGR of 8.5% over 2023-2029. Syphilis is a sexually transmitted disease caused by Treponema pallidum bacteria. Syphilis tests are used for screening and detection of antibodies against bacteria into the patients’ blood. There are various complications related to syphilis infection, such as infertility in both, men and women, ectopic pregnancy, cervical cancer in women and congenital mortality, and infections. The Primary segment anticipated to grow at significant CAGR over the forecast years. The first stage happens two to 12 weeks after exposure to the bacteria. During this stage, a smooth, red sore called a chancre develops on the genitals or in the mouth. It goes away on its own in a few weeks or months. A chancre is small and usually painless, so you may not even know it’s there. Blood tests can confirm the presence of antibodies that the body produces to fight infection. The antibodies to the syphilis-causing bacteria remain in your body for years, so the test can be used to determine a current or past infection which can anticipated the growth of syphilis testing market. Rising public awareness about syphilis treatment, increase in the occurrence of sexually transmitted disease, increasing government funding or investments on STD testing, Impact of social taboos and stigmas are a few factors driving the industry's growth over the forecasting period.

Syphilis Testing Market Key Developments:
In July 2019, the startup launched three new test kits, which will test for conditions such as chlamydia, gonorrhea, and syphilis.